263 related articles for article (PubMed ID: 12857950)
1. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.
Donaldson KM; Li W; Ching KA; Batalov S; Tsai CC; Joazeiro CA
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8892-7. PubMed ID: 12857950
[TBL] [Abstract][Full Text] [Related]
2. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation.
Seibenhener ML; Babu JR; Geetha T; Wong HC; Krishna NR; Wooten MW
Mol Cell Biol; 2004 Sep; 24(18):8055-68. PubMed ID: 15340068
[TBL] [Abstract][Full Text] [Related]
3. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
[TBL] [Abstract][Full Text] [Related]
4. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
[TBL] [Abstract][Full Text] [Related]
5. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
[TBL] [Abstract][Full Text] [Related]
6. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.
Chai Y; Berke SS; Cohen RE; Paulson HL
J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712
[TBL] [Abstract][Full Text] [Related]
7. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
Stenoien DL; Mielke M; Mancini MA
Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
[TBL] [Abstract][Full Text] [Related]
8. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.
Burnett B; Li F; Pittman RN
Hum Mol Genet; 2003 Dec; 12(23):3195-205. PubMed ID: 14559776
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
Jana NR; Nukina N
J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
[TBL] [Abstract][Full Text] [Related]
10. PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin.
Yang H; Yue HW; He WT; Hong JY; Jiang LL; Hu HY
FASEB J; 2018 Jun; 32(6):2923-2933. PubMed ID: 29401586
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
[TBL] [Abstract][Full Text] [Related]
13. The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1Up.
Riley BE; Xu Y; Zoghbi HY; Orr HT
J Biol Chem; 2004 Oct; 279(40):42290-301. PubMed ID: 15280365
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
15. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
Nozaki K; Onodera O; Takano H; Tsuji S
Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
[TBL] [Abstract][Full Text] [Related]
16. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
Kaytor MD; Wilkinson KD; Warren ST
J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
[TBL] [Abstract][Full Text] [Related]
17. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
Cummings CJ; Mancini MA; Antalffy B; DeFranco DB; Orr HT; Zoghbi HY
Nat Genet; 1998 Jun; 19(2):148-54. PubMed ID: 9620770
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.
Doss-Pepe EW; Stenroos ES; Johnson WG; Madura K
Mol Cell Biol; 2003 Sep; 23(18):6469-83. PubMed ID: 12944474
[TBL] [Abstract][Full Text] [Related]
19. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
Michalik A; Van Broeckhoven C
Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
[TBL] [Abstract][Full Text] [Related]
20. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
Matsumoto M
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
